Journal of the American Academy of Dermatology · 1996
A randomized trial of minoxidil in chemotherapy-induced alopecia.
Клиническое исследованиеСтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Duvic M, Lemak N A, Valero V, Hymes S R, Farmer K L, Hortobagyi G N, Trancik R J, Bandstra B A, Compton L D
Аннотация
BACKGROUND: Hair loss is a side effect of many chemotherapeutic agents, and patients have even refused possibly palliative or lifesaving drugs because they could not accept temporary or prolonged baldness. Topical minoxidil has been shown to be effective for androgenetic alopecia and alopecia areata.
OBJECTIVE: Our purpose was to investigate the value and safety of minoxidil in chemotherapy-induced hair loss.
METHODS: Twenty-two women who were facing adjuvant chemotherapy after breast surgery were registered in a protocol that used a 2% minoxidil topical solution or a placebo in a randomized double-blind trial.
RESULTS: There was a statistically significant difference (favoring minoxidil) in the interval from maximal hair loss to first regrowth. Thus the period of baldness was shortened (mean, 50.2 days) in the minoxidil group.
CONCLUSION: Minoxidil decreased the duration of alopecia caused by chemotherapy. There were no significant side effects.
OBJECTIVE: Our purpose was to investigate the value and safety of minoxidil in chemotherapy-induced hair loss.
METHODS: Twenty-two women who were facing adjuvant chemotherapy after breast surgery were registered in a protocol that used a 2% minoxidil topical solution or a placebo in a randomized double-blind trial.
RESULTS: There was a statistically significant difference (favoring minoxidil) in the interval from maximal hair loss to first regrowth. Thus the period of baldness was shortened (mean, 50.2 days) in the minoxidil group.
CONCLUSION: Minoxidil decreased the duration of alopecia caused by chemotherapy. There were no significant side effects.
Предметные рубрики MeSH
Administration, CutaneousAdultAlopeciaAntibiotics, AntineoplasticAntimetabolites, AntineoplasticAntineoplastic Agents, AlkylatingAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsChemotherapy, AdjuvantCyclophosphamideDouble-Blind MethodDoxorubicinFemaleFluorouracilHairHumansMiddle AgedMinoxidilPilot ProjectsPlacebosTime Factors